Mark Newpower
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark Newpower has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Lawrence Bronk
Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas
2 shared publicationsRadhe Mohan
Department of Radiation Physics, MD Anderson Cancer Center, Houston, TX 77030, USA
2 shared publicationsS Ahmad
University of Oklahoma Health Sciences Center, Oklahoma City, OK
2 shared publicationsY Chen
University of Oklahoma Health Sciences Center, Oklahoma City, OK
2 shared publicationsBing‐Hao Chiang
Department of Radiation Oncology University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA
1 shared publication- Christopher Ryan Peeler
Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
1 shared publication
Latest Publications
- Open Access
- 7 February 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (5)
Spot delivery error predictions for intensity modulated proton therapy using robustness analysis with machine learning
The purpose of this work is to assess the robustness of treatment plans when spot delivery errors were predicted with a machine learning (ML) model for intensity modulated proton therapy (IMPT). Over 6000 machine log files from delivered IMPT treatment plans were included in this study. From these log files, over 4.1 106 delivered proton spots were used to train the ML model. The presented model was tested and used to predict the spot position as well as the monitor units (MU) per spot, based on the original planning parameters. Two patient plans (one accelerated partial breast irradiation [APBI] and one ependymoma) were recalculated with the predicted spot position/MUs by the ML model and then were re‐analyzed for robustness. Plans with ML predicted spots were less robust than the original clinical plans. In the APBI plan, dosimetric changes to the left lung and heart were not clinically relevant. In the ependymoma plan, the hot spot in the brainstem decreased and the hot spot in the cervical cord increased. Despite these differences, after robustness analysis, both ML spot delivery error plans resulted in >95% of the CTV receiving >95% of the prescription dose. The presented workflow has the potential benefit of including realistic spots information for plan quality checks in IMPT. This work demonstrates that in the two example plans, the plans were still robust when accounting for spot delivery errors as predicted by the ML model.
- 7 February 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (5)
Open AccessSpot delivery error predictions for intensity modulated proton therapy using robustness analysis with machine learning
The purpose of this work is to assess the robustness of treatment plans when spot delivery errors were predicted with a machine learning (ML) model for intensity modulated proton therapy (IMPT). Over 6000 machine log files from delivered IMPT treatment plans were included in this study. From these log files, over 4.1 106 delivered proton spots were used to train the ML model. The presented model was tested and used to predict the spot position as well as the monitor units (MU) per spot, based on the original planning parameters. Two patient plans (one accelerated partial breast irradiation [APBI] and one ependymoma) were recalculated with the predicted spot position/MUs by the ML model and then were re‐analyzed for robustness. Plans with ML predicted spots were less robust than the original clinical plans. In the APBI plan, dosimetric changes to the left lung and heart were not clinically relevant. In the ependymoma plan, the hot spot in the brainstem decreased and the hot spot in the cervical cord increased. Despite these differences, after robustness analysis, both ML spot delivery error plans resulted in >95% of the CTV receiving >95% of the prescription dose. The presented workflow has the potential benefit of including realistic spots information for plan quality checks in IMPT. This work demonstrates that in the two example plans, the plans were still robust when accounting for spot delivery errors as predicted by the ML model.
- Open Access
- 1 June 2019
- Published by Elsevier in International Journal of Particle Therapy
- Vol. 6 (1) , 18-27
Comparing 2 Monte Carlo Systems in Use for Proton Therapy Research
Purpose: Several Monte Carlo transport codes are available for medical physics users. To ensure confidence in the accuracy of the codes, they must be continually cross-validated. This stud...
- 1 June 2019
- Published by Elsevier in International Journal of Particle Therapy
- Vol. 6 (1) , 18-27
Open AccessComparing 2 Monte Carlo Systems in Use for Proton Therapy Research
Purpose: Several Monte Carlo transport codes are available for medical physics users. To ensure confidence in the accuracy of the codes, they must be continually cross-validated. This stud...
- Open Access
- 1 June 2019
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 104 (2) , 316-324
Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness
- 1 June 2019
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 104 (2) , 316-324
Open AccessUsing the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness
- Open Access
- 21 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
A model for relative biological effectiveness of therapeutic proton beams based on a global fit of cell survival data
We introduce an approach for global fitting of the recently published high-throughput and high accuracy clonogenic cell-survival data for therapeutic scanned proton beams. Our fitting procedure accounts for the correlation between the cell-survival, the absorbed (physical) dose and the proton linear energy transfer (LET). The fitting polynomials and constraints have been constructed upon generalization of the microdosimetric kinetic model (gMKM) adapted to account for the low energy and high lineal-energy spectrum of the beam where the current radiobiological models may underestimate the reported relative biological effectiveness (RBE). The parameters (α, β) of the linear-quadratic (LQ) model calculated by the presented method reveal a smooth transition from low to high LETs which is an advantage of the current method over methods previously employed to fit the same clonogenic data. Finally, the presented approach provides insight into underlying microscopic mechanisms which, with future study, may help to elucidate radiobiological responses along the Bragg curve and resolve discrepancies between experimental data and current RBE models.
- 21 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-12
Open AccessA model for relative biological effectiveness of therapeutic proton beams based on a global fit of cell survival data
We introduce an approach for global fitting of the recently published high-throughput and high accuracy clonogenic cell-survival data for therapeutic scanned proton beams. Our fitting procedure accounts for the correlation between the cell-survival, the absorbed (physical) dose and the proton linear energy transfer (LET). The fitting polynomials and constraints have been constructed upon generalization of the microdosimetric kinetic model (gMKM) adapted to account for the low energy and high lineal-energy spectrum of the beam where the current radiobiological models may underestimate the reported relative biological effectiveness (RBE). The parameters (α, β) of the linear-quadratic (LQ) model calculated by the presented method reveal a smooth transition from low to high LETs which is an advantage of the current method over methods previously employed to fit the same clonogenic data. Finally, the presented approach provides insight into underlying microscopic mechanisms which, with future study, may help to elucidate radiobiological responses along the Bragg curve and resolve discrepancies between experimental data and current RBE models.
- 7 June 2016
- Published by Wiley in Medical Physics
- Vol. 43 (6Part15) , 3504-3505
SU-F-T-187: Quantifying Normal Tissue Sparing with 4D Robust Optimization of Intensity Modulated Proton Therapy
- 7 June 2016
- Published by Wiley in Medical Physics
- Vol. 43 (6Part15) , 3504-3505
SU-F-T-187: Quantifying Normal Tissue Sparing with 4D Robust Optimization of Intensity Modulated Proton Therapy
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part20) , 3460
SU‐E‐T‐544: Microscopic Dose Enhancement of Gold Nanoparticles in Water for Proton Therapy: A Simulation Study
Purpose: To quantify the microscopic dose and linear energy transfer (LET) enhancement of gold nanoparticles (GNPs) in water for proton therapy.Methods: The GEANT4 toolkit (version 10) with low energy electromagnetic classes was used to create a series of simulations where three radii (r=5, 20, 100 nm) of gold nanoparticles (GNPs) were irradiated with 5 × 106 80 MeV protons. A cubic detector (10 × 10 × 10 um, divided in 25 × 25 × 25 voxels) were placed in a water phantom where the GNP rests in the center. The size of incident proton beam was set to be same as the GNPs and perpendicularly aiming to the target. Dose deposited to each voxel were recorded to calculate the overall deposited dose and the dose‐averaged LET. The emitted secondary electron spectra were also collected in a spherical customized scorer (radius = 150 nm).Results: The average dose from a single GNP in a cubic water phantom was increased by 0.12 %, 1.12% and 2.3% and the mean dose‐averaged LET was increased by 5.87% and 27.67% and 0.31% for GNP radius of 5 nm, 20 nm and 100 nm, respectively.Conclusion: The dose enhancement effect from the presence of a single GNP was qualified in a water phantom. A significant increase in the mean dose‐averaged LET was found for 20 nm GNP.
- 29 June 2015
- Published by Wiley in Medical Physics
- Vol. 42 (6Part20) , 3460
SU‐E‐T‐544: Microscopic Dose Enhancement of Gold Nanoparticles in Water for Proton Therapy: A Simulation Study
Purpose: To quantify the microscopic dose and linear energy transfer (LET) enhancement of gold nanoparticles (GNPs) in water for proton therapy.Methods: The GEANT4 toolkit (version 10) with low energy electromagnetic classes was used to create a series of simulations where three radii (r=5, 20, 100 nm) of gold nanoparticles (GNPs) were irradiated with 5 × 106 80 MeV protons. A cubic detector (10 × 10 × 10 um, divided in 25 × 25 × 25 voxels) were placed in a water phantom where the GNP rests in the center. The size of incident proton beam was set to be same as the GNPs and perpendicularly aiming to the target. Dose deposited to each voxel were recorded to calculate the overall deposited dose and the dose‐averaged LET. The emitted secondary electron spectra were also collected in a spherical customized scorer (radius = 150 nm).Results: The average dose from a single GNP in a cubic water phantom was increased by 0.12 %, 1.12% and 2.3% and the mean dose‐averaged LET was increased by 5.87% and 27.67% and 0.31% for GNP radius of 5 nm, 20 nm and 100 nm, respectively.Conclusion: The dose enhancement effect from the presence of a single GNP was qualified in a water phantom. A significant increase in the mean dose‐averaged LET was found for 20 nm GNP.
- 29 May 2014
- Published by Wiley in Medical Physics
- Vol. 41 (6Part10) , 214-215
SU-E-J-247: A Simulation of X-Ray Emission with Gold Nanoparticle Irradiated by Energetic Proton Beam
- 29 May 2014
- Published by Wiley in Medical Physics
- Vol. 41 (6Part10) , 214-215
SU-E-J-247: A Simulation of X-Ray Emission with Gold Nanoparticle Irradiated by Energetic Proton Beam